Log in | Register

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 4, Issue 3

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 4, Issue 3 (2005)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 4, Issue 3 (2005)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Volume 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Implications of statin adverse effects in the elderly

Beatrice Alexandra Golomb

Pages: 389-397

Published online: 10 May 2005

AbstractforImplications of statin adverse effects in the elderly | References | PDF (120.2 KB)

241 Views
26 CrossRef citations
0Altmetric

Article

Adverse effects associated with SonoVue^® use

Guido Torzilli

Pages: 399-401

Published online: 10 May 2005

AbstractforAdverse effects associated with SonoVue^® use | References | PDF (53.1 KB)

109 Views
34 CrossRef citations
0Altmetric

Review

Article

Safety of lopinavir/ritonavir for the treatment of HIV-infection

Martin Vogel & Jürgen K Rockstroh

Pages: 403-420

Published online: 10 May 2005

AbstractforSafety of lopinavir/ritonavir for the treatment of HIV-infection | References | PDF (214.5 KB)

102 Views
14 CrossRef citations
0Altmetric

Article

Antimalarial drugs: QT prolongation and cardiac arrhythmias

Martin Traebert & Berengere Dumotier

Pages: 421-431

Published online: 10 May 2005

AbstractforAntimalarial drugs: QT prolongation and cardiac arrhythmias | References | PDF (137.3 KB)

287 Views
31 CrossRef citations
0Altmetric

Article

Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity

James P O’Callaghan & Krishnan Sriram

Pages: 433-442

Published online: 10 May 2005

AbstractforGlial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity | References | PDF (257.9 KB)

358 Views
197 CrossRef citations
0Altmetric

Article

The safety of cannabinoids for the treatment of multiple sclerosis

Paul F Smith

Pages: 443-456

Published online: 10 May 2005

AbstractforThe safety of cannabinoids for the treatment of multiple sclerosis | References | PDF (169 KB)

137 Views
6 CrossRef citations
0Altmetric

Article

Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity

Michaela Adamcová, Martin Šterba, Tomáš Šimunek, Anna Potácová, Olga Popelová, Yvona Mazurová & Vladimír Geršl

Pages: 457-472

Published online: 10 May 2005

AbstractforTroponin as a marker of myocardiac damage in drug-induced cardiotoxicity | References | PDF (176.8 KB)

193 Views
50 CrossRef citations
0Altmetric

Article

Efficacy and safety of basiliximab in kidney transplantation

Ugo Boggi, Fabio Vistoli, Stefano Signori, Marco Del Chiaro, Gabriella Amorese, Massimiliano Barsotti, Gaetano Rizzo, Piero Marchetti, Romano Danesi, Mario Del Tacca & Franco Mosca

Pages: 473-490

Published online: 10 May 2005

AbstractforEfficacy and safety of basiliximab in kidney transplantation | References | PDF (192.4 KB)

109 Views
5 CrossRef citations
0Altmetric

Article

The safety of rofecoxib

Michel Burnier

Pages: 491-499

Published online: 10 May 2005

AbstractforThe safety of rofecoxib | References | PDF (103.4 KB)

161 Views
31 CrossRef citations
0Altmetric

Article

The cerebrovascular risks associated with tamoxifen use

Cheryl Bushnell

Pages: 501-507

Published online: 10 May 2005

AbstractforThe cerebrovascular risks associated with tamoxifen use | References | PDF (88 KB)

87 Views
12 CrossRef citations
0Altmetric

Article

ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis

Icilio Cavero & William Crumb

Pages: 509-530

Published online: 10 May 2005

AbstractforICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis | References | PDF (225.2 KB)

161 Views
62 CrossRef citations
0Altmetric

Article

Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety

Thorsten Reffelmann & Robert A Kloner

Pages: 531-540

Published online: 10 May 2005

AbstractforPharmacotherapy of erectile dysfunction: focus on cardiovascular safety | References | PDF (122 KB)

108 Views
21 CrossRef citations
0Altmetric

Article

The role of antiplatelet therapy in the management of acute coronary syndromes

Gregory A Volturo, Jennifer L Mazzola & Karin Przylenk

Pages: 541-556

Published online: 10 May 2005

AbstractforThe role of antiplatelet therapy in the management of acute coronary syndromes | References | PDF (197.1 KB)

27 Views
6 CrossRef citations
0Altmetric

Article

The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients

Stephen J Wilson, Mark C Bellamy & Peter V Giannoudis

Pages: 557-570

Published online: 10 May 2005

AbstractforThe safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients | References | PDF (167.9 KB)

48 Views
1 CrossRef citations
0Altmetric

Article

Anticonvulsant hypersensitivity syndrome: a review

Nithya J Gogtay, Sandeep B Bavdekar & Nilima A Kshirsagar

Pages: 571-581

Published online: 10 May 2005

AbstractforAnticonvulsant hypersensitivity syndrome: a review | References | PDF (126.1 KB)

411 Views
50 CrossRef citations
0Altmetric

Article

Minimising the risk of heparin-induced osteoporosis during pregnancy

David Hawkins & Jeffrey Evans

Pages: 583-590

Published online: 10 May 2005

AbstractforMinimising the risk of heparin-induced osteoporosis during pregnancy | References | PDF (97.6 KB)

131 Views
27 CrossRef citations
0Altmetric

Article

Are rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors?

Muhammad Mamdani

Pages: 591-598

Published online: 10 May 2005

AbstractforAre rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors? | References | PDF (118.1 KB)

24 Views
1 CrossRef citations
0Altmetric

Article

Reactivation of hepatitis B virus with rituximab

Yutaka Tsutsumi, Hiroe Kanamori, Akio Mori, Junji Tanaka, Masahiro Asaka, Masahiro Imamura & Nobuo Masauzi

Pages: 599-608

Published online: 10 May 2005

AbstractforReactivation of hepatitis B virus with rituximab | References | PDF (116.8 KB)

284 Views
111 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 17 May 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study

Haiying Ding et al.

Review Article | Published online: 16 May 2024

Adverse tumor events induced by Ranitidine: an analysis based on the FAERS Database

Tian Liu et al.

Article | Published online: 16 May 2024

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Guixiang Chen et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.4, Iss.3, 2005)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?